Catherine Jomary

Catherine Jomary, PhD, is a highly experienced professional in the fields of cell and gene therapy, with extensive expertise in product process development, regulatory compliance, and quality assurance. Currently serving as the Product Process & Compliance Lead SME at IPS-Integrated Project Services since June 2021, Catherine has previously held significant roles at Biogen, Lonza, and Takeda, where contributions included overseeing gene therapy product phases and commercial launches. Additional experience encompasses positions at MeiraGTx, RoslinCT, and Baxter International, where responsibilities included managing development projects, regulatory interactions, and quality control operations. Catherine holds a Ph.D. in Molecular Pharmacology from Université Paul Sabatier Toulouse III and a Master's degree in Molecular Biology of Membranes and Cellular Interactions from Université Paris Cité.